US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

crane

142.65

+1.080.76%

Post-market: 142.600.00000.00%17:13 EDT

Volume:264.63K

Turnover:37.70M

Market Cap:8.20B

PE:28.22

High:143.85

Open:142.10

Low:140.97

Close:141.57

Loading ...

Overview Company News Filings

CR Double-Crane Pharma Gets Europe's Suitability Certificate for Dienogest

MT Newswires Live

GNRC or CR: Which Is the Better Value Stock Right Now?

New Strong Sell Stocks for December 20th

Press Release: enGene Reports Full Year 2024 Financial Results and Provides a Business Update

US lawmakers reject Republican bill to avert government shutdown

Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory Light Chain (AL) Amyloidosis

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

China Resources Pharmaceutical Boosts Stake in CR Boya

Tapestry, Inc. Releases FY2024 Corporate Responsibility Report

China Resources Double-Crane Pharmaceutical Passes GMP Compliance for Sugammadex Sodium

MT Newswires Live

Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)

Crane Company Receives ‘Buy’ Rating as Aerospace & Electronics Segment Drives Growth and Strong Balance Sheet Prospects

Journal of Clinical Oncology Publishes NXC-201 Positive Clinical Results in relapsed/refractory AL Amyloidosis

Hiab enters into a strategic HIAB dealer agreement with Ring Power Utility | Truck | Crane in the US

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

CR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%

MT Newswires Live

100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial

China Resources Beer Partners with CR Mixc Group

China Resources Double-Crane Pharmaceutical Gets Drug Registration for Neurological Disease Tablets

MT Newswires Live

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CR/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CR\",,,,,undefined,":{"symbol":"CR","market":"US","secType":"STK","nameCN":"crane","latestPrice":142.65,"timestamp":1744920000000,"preClose":141.57,"halted":0,"volume":264630,"hourTrading":{"tag":"盘后","latestPrice":142.595,"preClose":142.595,"latestTime":"17:13 EDT","volume":3647,"amount":520243.18,"timestamp":1744924403592},"delay":0,"floatShares":48596385,"shares":57484763,"eps":5.054545,"marketStatus":"Market Closed","change":1.08,"latestTime":"04-17 16:00:00 EDT","open":142.1,"high":143.845,"low":140.97,"amount":37701505.3125,"amplitude":0.020308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.054545,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":141.57,"dividendRate":0.005748,"preHourTrading":{"tag":"盘前","latestPrice":142.27,"preClose":141.57,"latestTime":"09:25 EDT","volume":14,"amount":1982.8802,"timestamp":1744896306340},"postHourTrading":{"tag":"盘后","latestPrice":142.595,"preClose":142.595,"latestTime":"17:13 EDT","volume":3647,"amount":520243.18,"timestamp":1744924403592},"volumeRatio":0.7046026155896769,"impliedVol":0.4963,"impliedVolPercentile":0.9602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CR\",,,,,undefined,":{"symbol":"CR","floatShares":48596385,"roa":"8.53%","roe":"17.87%","lyrEps":5.152097,"volumeRatio":0.7046026155896769,"shares":57484763,"dividePrice":0.82,"high":143.845,"amplitude":0.020308,"preClose":141.57,"low":140.97,"week52Low":127.04,"pbRate":"5.00","psRate":"3.85","week52High":188.52,"institutionHeld":0.6875,"latestPrice":142.65,"eps":5.054545,"divideRate":0.005748,"volume":264630,"delay":0,"ttmEps":5.054545,"open":142.1,"prevYearClose":151.75,"prevWeekClose":140.89,"prevMonthClose":153.18,"prevQuarterClose":153.18,"fiveDayClose":140.54,"twentyDayClose":153.17,"sixtyDayClose":161.87,"earningDate":1745769600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CR\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2494861278","title":"CR Double-Crane Pharma Gets Europe's Suitability Certificate for Dienogest","url":"https://stock-news.laohu8.com/highlight/detail?id=2494861278","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494861278?lang=en_us&edition=fundamental","pubTime":"2024-12-26 12:04","pubTimestamp":1735185865,"startTime":"0","endTime":"0","summary":"China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, Qinhuangdao Zizhu Pharmaceutical, received the Certificate of Suitability to Monograph of European Pharmacopoeia for the raw drug mater","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600062","BK0188","CR","BK0028","BK0010","BK0239","BK0175","BK0185","BK4161"],"gpt_icon":0},{"id":"2493956799","title":"GNRC or CR: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493956799","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493956799?lang=en_us&edition=fundamental","pubTime":"2024-12-24 00:40","pubTimestamp":1734972014,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Manufacturing - General Industrial sector have probably already heard of Generac Holdings  and Crane . But which of these two companies is the best option for those looking for undervalued stocks?Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.Generac Holdings and Crane are sporting Zacks Ranks of #2  and #4 , respectively, right now. This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that GNRC is likely seeing its earnings outlook improve to a greater extent. But this is just one piece of the puzzle for value investors.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fj4TPQveJWuth16WIsEVAw--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fj4TPQveJWuth16WIsEVAw--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gnrc-cr-better-value-stock-164014976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4096","BK4161","GNRC","LU1878469433.USD","LU0823414478.USD","LU2249611893.SGD","CR","BK4585","BK4588"],"gpt_icon":0},{"id":"2493542586","title":"New Strong Sell Stocks for December 20th","url":"https://stock-news.laohu8.com/highlight/detail?id=2493542586","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493542586?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:15","pubTimestamp":1734700500,"startTime":"0","endTime":"0","summary":"Here are three stocks added to the Zacks Rank #5  List today:. ICON ICLR is a provider of outsourced development and services to pharmaceutical, biotechnology, medical device and government and public health organizations. The Zacks Consensus Estimate for its current year earnings has been revised 7.3% downward over the last 60 days.BHP Group Limited BHP is one of the world's largest diversified resource companies with operations across several continents. The Zacks Consensus Estimate for its current year earnings has been revised 5.9% downward over the last 60 days.Crane Company CR is a manufacturer and seller of engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The Zacks Consensus Estimate for its current year earnings has been revised almost 5.7% downward over the last 60 days.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Days. Click to get t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0Y9Pa17EWKE7g9B40qB7NQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c1a5c7fadb2fecc08cc496de7c8904dd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0Y9Pa17EWKE7g9B40qB7NQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c1a5c7fadb2fecc08cc496de7c8904dd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-sell-stocks-december-20th-131500996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4168","LU0128525929.USD","LU0289739343.SGD","LU2362540622.SGD","LU0472753341.HKD","LU0426412945.USD","BK4585","LU0187121727.USD","LU0994945656.USD","LU0057025933.USD","LU1267930573.SGD","BK7095","CR","LU2244417387.USD","BHP.AU","LU0882574055.USD","LU2362541513.USD","LU0728928796.USD","LU0175139822.USD","ICLR","BK7507","LU1983260115.SGD","LU0708994859.HKD","LU1791710582.SGD","LU1267930813.SGD","LU0069063385.USD","BK4532","LU0792757196.USD","LU0310800379.SGD","LU0889566641.SGD","LU1043141123.HKD","LU0029864427.USD","LU0289961442.SGD","LU2324357040.USD","LU1121112475.USD","LU0114720955.EUR","LU2362541273.HKD","BK4588","LU0528227936.USD","LU1791710400.SGD","LU1804176565.USD","BHP","BK4121","BK7511","LU0426417589.USD","LU0511384066.AUD","LU1691799644.USD","BK4161","LU0289960550.SGD","LU1043141396.HKD"],"gpt_icon":0},{"id":"2492595481","title":"Press Release: enGene Reports Full Year 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2492595481","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492595481?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:05","pubTimestamp":1734642300,"startTime":"0","endTime":"0","summary":"BLA filing for detalimogene in BCG-unresponsive NMIBC with CIS on track for mid-2026. All cohorts of the Phase 2 LEGEND study now recruiting under updated protocol. Additional preliminary data from pivotal cohort anticipated in 2H 2025. Cash, cash equivalents and marketable securities of $297.9 million provide runway into 2027. \"Having demonstrated a 71% anytime complete response rate in the preliminary data from the LEGEND study's pivotal cohort of BCG-unresponsive NMIBC patients, initiated three additional NMIBC patient cohorts, and raised an additional $60 million in funding, enGene is in a strong clinical and financial position as we close the year,\" said Ron Cooper, Chief Executive Officer of enGene. \"With trial recruitment open across all cohorts, the profile of detalimogene continues to become clearer and stronger and, with the protocol enhancements now in place, we look forward to sharing LEGEND study updates across all cohorts expected in the second half of 2025.\". LEGEND stud","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","BK4135","BCG","ENGN","CTO","BK4160","BK4139","BK4161"],"gpt_icon":0},{"id":"2492453376","title":"US lawmakers reject Republican bill to avert government shutdown","url":"https://stock-news.laohu8.com/highlight/detail?id=2492453376","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492453376?lang=en_us&edition=fundamental","pubTime":"2024-12-20 04:05","pubTimestamp":1734638700,"startTime":"0","endTime":"0","summary":"WASHINGTON:The US House of Representatives on Thursday  overwhelmingly rejected a Republican-led funding Bill aimed at averting a government shutdown, with federal agencies due to run out of cash on Friday night and cease operations starting this weekend.The contentious legislation would have suspended the country's borrowing limit for President-elect Donald Trump's first two years in office and dozens of debt hawks in the Republican ranks rebelled against their own leadership to sink the package.It was a defeat for the Republican leader, who with tech billionaire Elon Musk - his incoming \"efficiency czar\" - had thrown his weight behind the plan.The retooled version was considered under a fast-track method that required two-thirds support but Democrats had been clear that they would deny Republicans the votes they needed to make up for the rebels in their ranks and it failed to win even a straightforward majority.Republican House Speaker Mike Johnson has been facing criticism from all ","market":"sg","thumbnail":"https://dam.mediacorp.sg/image/upload/s--mCsUpKBy--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_one-cms:core:watermark:ap_data-1,w_0.1/f_auto,q_auto/v1/one-cms/core/congress_budget_22334.jpg?itok=rByVFH4T","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--mCsUpKBy--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_one-cms:core:watermark:ap_data-1,w_0.1/f_auto,q_auto/v1/one-cms/core/congress_budget_22334.jpg?itok=rByVFH4T"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/world/us-lawmakers-reject-republican-bill-avert-government-shutdown-4817531","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["CR","BK4161"],"gpt_icon":1},{"id":"2492179098","title":"Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory Light Chain (AL) Amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2492179098","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492179098?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:35","pubTimestamp":1734618900,"startTime":"0","endTime":"0","summary":"Immix Biopharma, Inc. (Nasdaq:IMMX)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/19/2999975/0/en/Immix-Biopharma-Announces-Positive-U-S-Clinical-Data-From-First-Four-Patients-in-NEXICART-2-U-S-Trial-of-sterically-optimized-CAR-T-NXC-201-in-relapsed-refractory-Light-Chain-AL-Am.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B66KJ199.SGD","IE00B19Z6F94.USD","BK4022","CRS","BK4161","IE0031619046.USD","AL","BK4006","IE00B19Z4B17.USD","ODD","CR","BK4572","BK4183","LU2065731478.USD","NXC","BK4104","IE0034390439.USD","BK4230","CAR","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"2492127098","title":"Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2492127098","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492127098?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:05","pubTimestamp":1734613500,"startTime":"0","endTime":"0","summary":"APOLLO study investigating MT-601 in patients with relapsed lymphoma: 78% of patients achieved objective response rates, with 44.4% demonstrating complete response (CR) MT-601 was observed to be well ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/19/2999831/0/en/Marker-Therapeutics-Provides-a-Clinical-Update-on-MT-601-in-Patients-with-Lymphoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4161","CRS","BK4022","BK4142","MAR","LU2065731478.USD","IE00B7SZL793.SGD","BK4139","CR","BK4006","LU1718418525.SGD","BK4230","IE00B19Z4B17.USD","CAR","IE00B66KJ199.SGD","IE0031619046.USD","BK4585","BK4561","LENZ","MT"],"gpt_icon":0},{"id":"2492184756","title":"China Resources Pharmaceutical Boosts Stake in CR Boya","url":"https://stock-news.laohu8.com/highlight/detail?id=2492184756","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492184756?lang=en_us&edition=fundamental","pubTime":"2024-12-18 22:42","pubTimestamp":1734532933,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update. China Resources Pharmaceutical Group Ltd. has increased its stake in CR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-resources-pharmaceutical-boosts-stake-in-cr-boya?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-resources-pharmaceutical-boosts-stake-in-cr-boya?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CR","BK4161"],"gpt_icon":0},{"id":"2492186317","title":"Tapestry, Inc. Releases FY2024 Corporate Responsibility Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2492186317","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492186317?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:00","pubTimestamp":1734526800,"startTime":"0","endTime":"0","summary":"NEW YORK, December 18, 2024----Tapestry, Inc. , a house of iconic accessories and lifestyle brands consisting of Coach, Kate Spade, and Stuart Weitzman, today released its Fiscal Year 2024  Corporate Responsibility  report. The report details the company’s progress and achievements in sustainability, social impact and community building over the past year. The company’s framework, The Fabric of Change, encapsulates its vision for a better-made future.\"We believe investing in our communities, people and sustainability initiatives drives innovation and long-term success and resilience for Tapestry and our portfolio of brands,\" said Joanne Crevoiserat, Chief Executive Officer of Tapestry, Inc. \"I am incredibly proud of the milestones our teams achieved in the last year, and we continue to see opportunities ahead.\". Leveraged innovation to be a more responsible and sustainable company. In FY2024, Tapestry’s Scope 1 and 2 GHG emissions were reduced by 84% compared to our FY2021 baseline. Th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tezAmNbmDcTvh9_oPOUo1A--~B/aD0yMDY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8718ee232a60e9d03e276c017334b76d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tezAmNbmDcTvh9_oPOUo1A--~B/aD0yMDY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8718ee232a60e9d03e276c017334b76d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tapestry-inc-releases-fy2024-corporate-130000202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0310800965.SGD","LU0320765489.SGD","BK4161","LU0128525689.USD","LU0070302665.USD","BK4202","LU0208291251.USD","TPR","BK4516","BK4585","LU1267930227.SGD","LU0052756011.USD","BK4588","CR"],"gpt_icon":0},{"id":"2492925209","title":"China Resources Double-Crane Pharmaceutical Passes GMP Compliance for Sugammadex Sodium","url":"https://stock-news.laohu8.com/highlight/detail?id=2492925209","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492925209?lang=en_us&edition=fundamental","pubTime":"2024-12-18 12:28","pubTimestamp":1734496109,"startTime":"0","endTime":"0","summary":"China Resources Double-Crane Pharmaceutical (SHA:600062) passed the good manufacturing practice compliance inspection for its sugammadex sodium injection.Sugammadex sodium can be used to treat neuromu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600062","CR","BK0010","BK0175","BK4161","BK0188","BK0239","BK0185","BK0028"],"gpt_icon":0},{"id":"2492959531","title":"Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492959531","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492959531?lang=en_us&edition=fundamental","pubTime":"2024-12-17 19:30","pubTimestamp":1734435000,"startTime":"0","endTime":"0","summary":"In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall response rate (ORR) of 21% (6 confirmed responses, 1 response awaiting confir","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/17/2998078/0/en/Affimed-Reports-Positive-Clinical-Update-on-AFM24-Atezolizumab-Combination-Therapy-in-Non-Small-Cell-Lung-Cancer-NSCLC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["L","BK4599","OS","PFS","BK4211","AE","PPS","ALT","BK4138","PR","LU0053666078.USD","FAS","BK4107","BK4097","BK4588","BK4195","CR","BK4161","BK4139","BK4213","BK4585","AST","LU1878469433.USD"],"gpt_icon":0},{"id":"2491690725","title":"Crane Company Receives ‘Buy’ Rating as Aerospace & Electronics Segment Drives Growth and Strong Balance Sheet Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2491690725","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491690725?lang=en_us&edition=fundamental","pubTime":"2024-12-16 23:05","pubTimestamp":1734361547,"startTime":"0","endTime":"0","summary":"Crane Company (CR – Research Report), the Industrials sector company, was revisited by a Wall Street analyst today. Analyst Matt Summerville from D...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/crane-company-receives-buy-rating-as-aerospace-electronics-segment-drives-growth-and-strong-balance-sheet-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/crane-company-receives-buy-rating-as-aerospace-electronics-segment-drives-growth-and-strong-balance-sheet-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CR"],"gpt_icon":0},{"id":"2491773692","title":"Journal of Clinical Oncology Publishes NXC-201 Positive Clinical Results in relapsed/refractory AL Amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2491773692","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491773692?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:48","pubTimestamp":1734360480,"startTime":"0","endTime":"0","summary":"Chimeric antigen receptor T-cell (CAR-T) cell therapy NXC-201 is a novel approach to treat relapsed/refractory AL Amyloidosis NXC-201 demonstrated compelling clinical activity, rapid and deep complete","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997631/0/en/Journal-of-Clinical-Oncology-Publishes-NXC-201-Positive-Clinical-Results-in-relapsed-refractory-AL-Amyloidosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AL","BK4104","BK4161","IE0031619046.USD","CRS","IE0034390439.USD","ODD","BK4572","BK4006","IE00B19Z6F94.USD","LU2065731478.USD","BK4230","CR","BK4022","CAR","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4183","NXC","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2491693172","title":"Hiab enters into a strategic HIAB dealer agreement with Ring Power Utility | Truck | Crane in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2491693172","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491693172?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354000,"startTime":"0","endTime":"0","summary":"CARGOTEC CORPORATION, PRESS RELEASE, 16 DECEMBER 2024 AT 3:00 PM EET. Hiab, part of Cargotec, has signed a strategic HIAB loader cranes dealer agreement with Ring Power Utility | Truck | Crane in the US. The agreement comprises HIAB loader cranes, as well as services.Founded in 2008, Ring Power Utility | Truck | Crane has grown into a leader in utility equipment, vocational trucks, and cranes, offering top-tier products from world-class brands and delivering innovative solutions, exceptional service, and lasting value through 11 U.S. locations.“Hiab is looking for future growth, and an important part of that is to further expand our leading position in the growing North American markets. The cooperation that we now embark on with Ring Power Utility | Truck | Crane will greatly support our ambitions in this,” saysPauliina Kunvik, SVP Sales & Services, Hiab USA. \"Ring Power Utility | Truck | Crane is strategically very well positioned in the US and their sales and services organisations ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PDM_IhgueS2wUqxVlsEf_w--~B/aD00MDt3PTE5ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/794f6bc04115d42caf9ef72873ba235a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PDM_IhgueS2wUqxVlsEf_w--~B/aD00MDt3PTE5ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/794f6bc04115d42caf9ef72873ba235a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hiab-enters-strategic-hiab-dealer-130000311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4084","BK4161","CYJBY","BK4213","CR","PW","CYJBF","REI","BK4234"],"gpt_icon":0},{"id":"2491277693","title":"BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2491277693","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491277693?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354000,"startTime":"0","endTime":"0","summary":"Improved median overall survival (OS) for Mec-V treated patients with treatment-refractory non-small cell lung cancer (NSCLC) expressing mutated KRAS (mKRAS) as compared to Mec-V treated patient with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997463/0/en/BioAtla-Presented-Data-Characterizing-Mutated-KRAS-Genotype-and-Clinical-Outcomes-in-Patients-with-Advanced-NSCLC-Treated-with-Mecbotamab-Vedotin-Mec-V-a-CAB-AXL-ADC-at-the-IASLC-2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","IE0031619046.USD","AEIS","AXL","BAS","IE00B66KJ199.SGD","BK4231","BK4139","OS","BK4157","BK4097","CAB","BK4124","IE00B19Z4B17.USD","IE00B7SZL793.SGD","ADC","BCAB","CR","BK4080"],"gpt_icon":0},{"id":"2491636493","title":"CR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491636493","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491636493?lang=en_us&edition=fundamental","pubTime":"2024-12-16 12:58","pubTimestamp":1734325129,"startTime":"0","endTime":"0","summary":"China Resources Double-Crane Pharmaceutical's  nine drugs were selected for China's centralized drug procurement bid, according to a Shanghai Stock Exchange disclosure on Saturday.The drugs are sugammadex sodium injection, mirabegron extended-release tablets, phloroglucinol injection, potassium chloride injection, roxatidine acetate hydrochloride for injection, sodium lactate ringer's injection, sodium bicarbonate ringer's injection, epalrestat tablets, and apremilast tablets.The pharmaceutical company's amikacin sulfate injection, peramivir injection, and aminophylline injection also participated in the bidding but were not shortlisted.The company's shares dropped less than 3% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600062","BK0028","BK0239","BK0188","BK0175","BK0185","BK4161","CR","BK0010"],"gpt_icon":0},{"id":"2490138759","title":"100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490138759","media":"ACCESSWIRE","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490138759?lang=en_us&edition=fundamental","pubTime":"2024-12-12 22:00","pubTimestamp":1734012000,"startTime":"0","endTime":"0","summary":"Two of three patients achieved both complete remission and MRD-negative status. High response rates observed in earlier studies continue in ongoing mipletamig trial. \"Achieving remission in all three Cohort 1 patients is highly encouraging, particularly when viewed alongside prior trial results. Notably, two of these three patients achieved MRD-negative status, a critical outcome indicating that even the most sensitive diagnostic methods detect no remaining cancer cells. This result is strongly associated with longer-lasting remissions and improved survival rates,\" said Dirk Huebner, MD, Chief Medical Officer at Aptevo. \"What makes these outcomes even more compelling is that one of the MRD-negative patients had a TP53 mutation, a subgroup known for its poor prognosis due to chemotherapy resistance, genetic instability, and overall treatment challenges. This growing body of data underscores mipletamig's p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/100-patients-achieve-remission-within-140000631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","BK4139","CR","APVO"],"gpt_icon":0},{"id":"2490099608","title":"China Resources Beer Partners with CR Mixc Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2490099608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490099608?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:09","pubTimestamp":1734001789,"startTime":"0","endTime":"0","summary":"China Resources Beer (Holdings) Co (HK:0291) has released an update. China Resources Beer (Holdings) Co has announced a new framework agreement wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-resources-beer-partners-with-cr-mixc-group?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-resources-beer-partners-with-cr-mixc-group?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4161","CR"],"gpt_icon":0},{"id":"2490582220","title":"China Resources Double-Crane Pharmaceutical Gets Drug Registration for Neurological Disease Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2490582220","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490582220?lang=en_us&edition=fundamental","pubTime":"2024-12-12 14:28","pubTimestamp":1733984925,"startTime":"0","endTime":"0","summary":"China Resources Double-Crane Pharmaceutical (SHA:600062) subsidiary Hunan Xiangzhong Pharmaceutical obtained a drug registration for its sodium valproate sustained-release tablets from China's drug ad","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["600062","BK0188","BK0010","BK0239","BK0185","BK0028","BK4161","CR","BK0175"],"gpt_icon":0},{"id":"2490854140","title":"ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2490854140","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490854140?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:30","pubTimestamp":1733920200,"startTime":"0","endTime":"0","summary":"ZYNLONTA in combination with glofitamab demonstrated clinically meaningful benefit with 94% best ORR and 72% CR rate. Safety data show no dose-limiting toxicities , no high-grade cytokine release syndrome  or high-grade immune effector cell-associated neurotoxicity syndrome  across all patients. LAUSANNE, Switzerland, Dec. 11, 2024 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of ZYNLONTA in combination with the bispecific antibody glofitamab  in patients with relapsed or refractory diffuse large B-cell lymphoma .\"We are excited by the strong initial results observed with ZYNLONTA plus glofitamab in second line plus patients with relapsed or refractory DLBCL,\" said Mohamed Zaki, MD, PhD, Chief Medical Officer of ADC Therapeutics. \"We believe these data support our hypothesis that comb","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Et0V8U3X6l.Laaek.1Xhrg--~B/aD0yNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b45d5be0d129d2f2b168ba1839a068c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/adc-therapeutics-announces-positive-initial-123000966.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adc-therapeutics-announces-positive-initial-123000966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4213","IE00B66KJ199.SGD","ADCT","BK4231","PR","LENZ","BK4505","CRS","IE0031619046.USD","BK4006","CR","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4161","ADC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CR\",params:#limit:5,,,undefined,":[{"date":"2025-04-28","symbol":"CR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.29,"defaultRemindTime":1745870400000,"name":null,"time":"Post Market","dateTimestamp":1745812800000,"actualEps":null},{"date":"2025-02-28","symbol":"CR","amount":0.23,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-28","defaultRemindTime":1740753000000,"name":"crane","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-12","payableDate":"2025-02-28","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-12"},{"market":"US","date":"2025-01-27","symbol":"CR","fiscalQuarterEnding":"2024/12","expectedEps":1.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1737954000000,"reportTimeType":"post","actualEps":1.26},{"date":"2024-11-29","symbol":"CR","amount":0.205,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-29","defaultRemindTime":1732890600000,"name":"crane","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-11","payableDate":"2024-11-29","currency":"USD","dateTimestamp":1732856400000,"payDate":"2024-12-11"},{"date":"2024-10-28","symbol":"CR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":1.31,"defaultRemindTime":1730145600000,"name":null,"time":"Post Market","dateTimestamp":1730088000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CR\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":"2017-02-28","paymentDate":"2017-03-09","value":0.33,"currency":"USD"},{"executeDate":"2017-05-26","recordDate":"2017-05-31","paymentDate":"2017-06-09","value":0.33,"currency":"USD"},{"executeDate":"2017-08-29","recordDate":"2017-08-31","paymentDate":"2017-09-08","value":0.33,"currency":"USD"},{"executeDate":"2017-11-29","recordDate":"2017-11-30","paymentDate":"2017-12-08","value":0.33,"currency":"USD"},{"executeDate":"2018-02-27","recordDate":"2018-02-28","paymentDate":"2018-03-09","value":0.35,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.6667,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CR","date":"2025-04-17","current":27.614923,"percent":0.604065,"low":8.74154,"twenty":14.045235,"median":24.592932,"eighty":35.764062,"high":224.415426,"avg":33.940929,"sd":39.655861,"marketCap":8138117897},"quantilePoints":[{"date":"2020-04-24","current":22.63042,"twenty":14.741964,"median":18.772876,"eighty":23.870847,"marketCap":3016635006},{"date":"2020-05-01","current":26.230548,"twenty":14.741964,"median":18.950122,"eighty":24.584825,"marketCap":2982413319},{"date":"2020-05-08","current":27.449269,"twenty":14.741964,"median":18.999018,"eighty":24.821141,"marketCap":3120981901},{"date":"2020-05-15","current":24.160252,"twenty":14.741964,"median":19.07024,"eighty":24.906887,"marketCap":2747020666},{"date":"2020-05-22","current":26.439617,"twenty":14.741964,"median":19.160985,"eighty":25.341628,"marketCap":3006184499},{"date":"2020-05-29","current":28.413028,"twenty":14.741964,"median":19.216082,"eighty":25.710674,"marketCap":3230561239},{"date":"2020-06-05","current":33.588768,"twenty":14.741964,"median":19.237422,"eighty":26.160178,"marketCap":3819042872},{"date":"2020-06-12","current":28.05608,"twenty":14.741964,"median":19.280168,"eighty":26.565059,"marketCap":3189976299},{"date":"2020-06-19","current":28.040782,"twenty":14.741964,"median":19.30144,"eighty":26.931579,"marketCap":3188236945},{"date":"2020-06-26","current":28.73428,"twenty":14.741964,"median":19.376127,"eighty":27.12269,"marketCap":3267087686},{"date":"2020-07-02","current":29.529764,"twenty":14.741964,"median":19.392132,"eighty":27.321969,"marketCap":3357534124},{"date":"2020-07-10","current":27.913301,"twenty":14.741964,"median":19.430021,"eighty":27.459735,"marketCap":3173742323},{"date":"2020-07-17","current":30.717889,"twenty":14.741964,"median":19.444135,"eighty":27.610101,"marketCap":3492623996},{"date":"2020-07-24","current":30.891264,"twenty":14.741964,"median":19.472413,"eighty":27.833259,"marketCap":3512336681},{"date":"2020-07-31","current":87.533402,"twenty":14.74899,"median":19.495965,"eighty":27.94019,"marketCap":3282502591},{"date":"2020-08-07","current":93.258585,"twenty":14.767286,"median":19.525503,"eighty":28.009625,"marketCap":3497196945},{"date":"2020-08-14","current":94.264361,"twenty":14.787765,"median":19.544175,"eighty":28.04746,"marketCap":3534913520},{"date":"2020-08-21","current":87.719084,"twenty":14.813662,"median":19.570486,"eighty":28.081529,"marketCap":3289465651},{"date":"2020-08-28","current":90.040104,"twenty":14.83771,"median":19.594842,"eighty":28.170784,"marketCap":3376503903},{"date":"2020-09-04","current":88.260655,"twenty":14.871894,"median":19.605519,"eighty":28.267865,"marketCap":3309774577},{"date":"2020-09-11","current":84.237554,"twenty":14.936445,"median":19.626415,"eighty":28.310525,"marketCap":3158908274},{"date":"2020-09-18","current":81.978428,"twenty":15.011846,"median":19.656053,"eighty":28.373051,"marketCap":3074191042},{"date":"2020-09-25","current":76.779343,"twenty":15.041272,"median":19.669528,"eighty":28.409968,"marketCap":2879225359},{"date":"2020-10-02","current":76.965025,"twenty":15.066218,"median":19.682881,"eighty":28.47471,"marketCap":2886188419},{"date":"2020-10-09","current":80.137085,"twenty":15.081973,"median":19.70422,"eighty":28.560476,"marketCap":3005140696},{"date":"2020-10-16","current":84.253027,"twenty":15.124703,"median":19.713849,"eighty":28.62779,"marketCap":3159488529},{"date":"2020-10-23","current":85.320697,"twenty":15.162424,"median":19.729877,"eighty":28.703268,"marketCap":3199526125},{"date":"2020-10-30","current":136.527006,"twenty":15.223621,"median":19.752233,"eighty":28.737446,"marketCap":2948983334},{"date":"2020-11-06","current":142.122596,"twenty":15.260409,"median":19.772138,"eighty":28.792366,"marketCap":3069848070},{"date":"2020-11-13","current":165.258207,"twenty":15.260409,"median":19.790516,"eighty":28.85843,"marketCap":3569577265},{"date":"2020-11-20","current":177.390952,"twenty":15.260409,"median":19.802914,"eighty":28.931965,"marketCap":3831644553},{"date":"2020-11-27","current":191.003299,"twenty":15.260409,"median":19.824132,"eighty":28.993533,"marketCap":4125671266},{"date":"2020-12-04","current":198.293707,"twenty":15.260409,"median":19.834923,"eighty":29.072788,"marketCap":4283144070},{"date":"2020-12-11","current":204.884666,"twenty":15.277405,"median":19.845593,"eighty":29.204431,"marketCap":4425508783},{"date":"2020-12-18","current":208.059087,"twenty":15.319129,"median":19.880269,"eighty":29.408025,"marketCap":4494076277},{"date":"2020-12-24","current":206.848503,"twenty":15.339718,"median":19.900532,"eighty":29.534806,"marketCap":4467927656},{"date":"2020-12-31","current":208.919947,"twenty":15.365764,"median":19.915811,"eighty":29.796111,"marketCap":4512670852},{"date":"2021-01-08","current":218.147289,"twenty":15.386249,"median":19.927575,"eighty":30.133245,"marketCap":4711981450},{"date":"2021-01-15","current":217.178822,"twenty":15.463133,"median":19.955186,"eighty":30.348098,"marketCap":4691062553},{"date":"2021-01-22","current":216.990509,"twenty":15.518993,"median":19.983043,"eighty":30.612845,"marketCap":4686994990},{"date":"2021-01-29","current":24.296226,"twenty":15.546124,"median":20.000911,"eighty":30.612845,"marketCap":4397616921},{"date":"2021-02-05","current":26.22567,"twenty":15.604175,"median":20.036867,"eighty":30.612845,"marketCap":4746846277},{"date":"2021-02-12","current":26.752174,"twenty":15.64869,"median":20.047071,"eighty":30.612845,"marketCap":4842143473},{"date":"2021-02-19","current":27.198418,"twenty":15.679949,"median":20.069656,"eighty":30.612845,"marketCap":4922913657},{"date":"2021-02-26","current":26.948508,"twenty":15.757032,"median":20.101665,"eighty":30.612845,"marketCap":4877680001},{"date":"2021-03-05","current":28.764142,"twenty":16.078184,"median":20.131636,"eighty":30.613864,"marketCap":5206309765},{"date":"2021-03-12","current":30.119103,"twenty":16.146147,"median":20.17181,"eighty":30.613864,"marketCap":5451557630},{"date":"2021-03-19","current":30.222173,"twenty":16.146147,"median":20.191936,"eighty":30.619304,"marketCap":5470213373},{"date":"2021-03-26","current":30.595804,"twenty":16.155113,"median":20.208951,"eighty":30.618171,"marketCap":5537840438},{"date":"2021-04-01","current":30.605466,"twenty":16.155113,"median":20.23058,"eighty":30.618171,"marketCap":5539589413},{"date":"2021-04-09","current":30.682769,"twenty":16.146147,"median":20.256725,"eighty":30.624072,"marketCap":5553581220},{"date":"2021-04-16","current":30.421872,"twenty":16.146147,"median":20.279169,"eighty":30.659957,"marketCap":5506358873},{"date":"2021-04-23","current":30.705316,"twenty":16.146147,"median":20.301119,"eighty":30.68362,"marketCap":5557662164},{"date":"2021-04-30","current":30.296255,"twenty":16.155113,"median":20.344302,"eighty":30.707893,"marketCap":5483622187},{"date":"2021-05-07","current":25.569844,"twenty":16.155113,"median":20.376409,"eighty":30.707893,"marketCap":5794126672},{"date":"2021-05-14","current":25.399722,"twenty":16.199938,"median":20.42789,"eighty":30.707893,"marketCap":5755577038},{"date":"2021-05-21","current":24.309395,"twenty":16.338001,"median":20.491036,"eighty":30.707893,"marketCap":5508508935},{"date":"2021-05-28","current":24.613553,"twenty":16.445582,"median":20.602521,"eighty":30.707893,"marketCap":5577431007},{"date":"2021-06-04","current":24.257843,"twenty":16.445582,"median":20.635149,"eighty":30.707893,"marketCap":5496827228},{"date":"2021-06-11","current":23.729434,"twenty":16.445582,"median":20.724193,"eighty":30.707893,"marketCap":5377089732},{"date":"2021-06-18","current":22.296285,"twenty":16.445582,"median":20.784488,"eighty":30.707893,"marketCap":5052338277},{"date":"2021-06-25","current":23.739744,"twenty":16.445582,"median":20.844829,"eighty":30.707893,"marketCap":5379426073},{"date":"2021-07-02","current":24.116075,"twenty":16.637435,"median":20.901381,"eighty":30.707893,"marketCap":5464702534},{"date":"2021-07-09","current":24.409922,"twenty":17.169936,"median":20.986777,"eighty":30.707893,"marketCap":5531288264},{"date":"2021-07-16","current":23.314439,"twenty":17.256001,"median":21.022105,"eighty":30.707893,"marketCap":5283051990},{"date":"2021-07-23","current":23.799029,"twenty":17.256001,"median":21.108637,"eighty":30.707893,"marketCap":5392860036},{"date":"2021-07-30","current":16.221256,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5679061858},{"date":"2021-08-06","current":16.529487,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5786973465},{"date":"2021-08-13","current":17.085494,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5981631539},{"date":"2021-08-20","current":16.514415,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5781696589},{"date":"2021-08-27","current":17.391968,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":6088928007},{"date":"2021-09-03","current":16.290002,"twenty":15.768581,"median":21.108637,"eighty":30.707893,"marketCap":5703129776},{"date":"2021-09-10","current":15.723947,"twenty":15.757032,"median":21.108637,"eighty":30.707893,"marketCap":5504953785},{"date":"2021-09-17","current":15.378954,"twenty":15.742757,"median":21.108637,"eighty":30.707893,"marketCap":5384171968},{"date":"2021-09-24","current":15.594993,"twenty":15.679949,"median":21.108637,"eighty":30.707893,"marketCap":5459807184},{"date":"2021-10-01","current":16.263207,"twenty":15.679949,"median":21.108637,"eighty":30.707893,"marketCap":5693748664},{"date":"2021-10-08","current":16.043818,"twenty":15.679949,"median":21.108637,"eighty":30.707893,"marketCap":5616940810},{"date":"2021-10-15","current":15.605042,"twenty":15.643409,"median":21.108637,"eighty":30.707893,"marketCap":5463325101},{"date":"2021-10-22","current":15.794285,"twenty":15.639757,"median":21.108637,"eighty":30.707893,"marketCap":5529579204},{"date":"2021-10-29","current":14.76593,"twenty":15.597281,"median":21.108637,"eighty":30.707893,"marketCap":6055507796},{"date":"2021-11-05","current":15.208034,"twenty":15.546124,"median":21.108637,"eighty":30.707893,"marketCap":6236814727},{"date":"2021-11-12","current":15.298251,"twenty":15.518993,"median":21.108637,"eighty":30.707893,"marketCap":6273812781},{"date":"2021-11-19","current":14.851461,"twenty":15.463133,"median":21.108637,"eighty":30.707893,"marketCap":6090584325},{"date":"2021-11-26","current":14.333071,"twenty":15.432575,"median":21.108637,"eighty":30.707893,"marketCap":5877992336},{"date":"2021-12-03","current":14.039507,"twenty":15.386249,"median":21.108637,"eighty":30.707893,"marketCap":5757601844},{"date":"2021-12-10","current":14.812797,"twenty":15.373275,"median":21.108637,"eighty":30.707893,"marketCap":6074728017},{"date":"2021-12-17","current":13.748807,"twenty":15.338429,"median":21.108637,"eighty":30.707893,"marketCap":5638385894},{"date":"2021-12-23","current":14.274358,"twenty":15.317813,"median":21.108637,"eighty":30.707893,"marketCap":5853914237},{"date":"2021-12-31","current":14.567922,"twenty":15.293897,"median":21.108637,"eighty":30.707893,"marketCap":5974304729},{"date":"2022-01-07","current":15.013279,"twenty":15.255263,"median":21.086933,"eighty":30.706604,"marketCap":6156945913},{"date":"2022-01-14","current":15.296819,"twenty":15.234158,"median":21.086933,"eighty":30.706604,"marketCap":6273225510},{"date":"2022-01-21","current":14.26147,"twenty":15.159469,"median":21.086933,"eighty":30.706604,"marketCap":5848628801},{"date":"2022-01-28","current":13.473236,"twenty":15.141331,"median":21.086933,"eighty":30.706604,"marketCap":5866246922},{"date":"2022-02-04","current":13.791554,"twenty":15.108005,"median":21.086933,"eighty":30.706604,"marketCap":6004842805},{"date":"2022-02-11","current":13.714672,"twenty":15.072408,"median":21.086933,"eighty":30.706604,"marketCap":5971368375},{"date":"2022-02-18","current":13.760532,"twenty":15.03684,"median":21.086933,"eighty":30.706604,"marketCap":5991335579},{"date":"2022-02-25","current":13.698487,"twenty":15.01748,"median":21.086933,"eighty":30.706604,"marketCap":5964321127},{"date":"2022-03-04","current":13.275413,"twenty":15.000697,"median":21.086933,"eighty":30.706604,"marketCap":5780114910},{"date":"2022-03-11","current":13.404745,"twenty":14.95296,"median":21.086933,"eighty":30.706604,"marketCap":5836425811},{"date":"2022-03-18","current":14.316596,"twenty":14.909849,"median":21.086933,"eighty":30.706604,"marketCap":6233446103},{"date":"2022-03-25","current":14.323128,"twenty":14.844637,"median":21.086933,"eighty":30.706604,"marketCap":6236290088},{"date":"2022-04-01","current":14.200329,"twenty":14.811668,"median":21.086933,"eighty":30.706604,"marketCap":6182823172},{"date":"2022-04-08","current":13.370779,"twenty":14.787157,"median":21.086933,"eighty":30.706604,"marketCap":5821637090},{"date":"2022-04-14","current":13.605352,"twenty":14.765711,"median":21.086933,"eighty":30.706604,"marketCap":5923770233},{"date":"2022-04-22","current":13.520383,"twenty":14.746344,"median":21.086933,"eighty":30.706604,"marketCap":5886774696},{"date":"2022-04-29","current":12.486253,"twenty":14.722676,"median":21.019089,"eighty":30.706604,"marketCap":5394061408},{"date":"2022-05-06","current":12.456696,"twenty":14.697062,"median":20.987955,"eighty":30.706604,"marketCap":5381292864},{"date":"2022-05-13","current":11.781959,"twenty":14.669658,"median":20.987955,"eighty":30.706604,"marketCap":5089806167},{"date":"2022-05-20","current":11.653499,"twenty":14.65307,"median":20.987955,"eighty":30.706604,"marketCap":5034311584},{"date":"2022-05-27","current":12.38533,"twenty":14.632214,"median":20.987955,"eighty":30.706604,"marketCap":5350462540},{"date":"2022-06-03","current":12.325642,"twenty":14.611294,"median":20.987955,"eighty":30.706604,"marketCap":5324677178},{"date":"2022-06-10","current":11.976595,"twenty":14.57907,"median":20.987955,"eighty":30.706604,"marketCap":5173888868},{"date":"2022-06-17","current":10.930751,"twenty":14.551074,"median":20.987955,"eighty":30.706604,"marketCap":4722084488},{"date":"2022-06-24","current":11.496493,"twenty":14.512301,"median":20.989133,"eighty":30.707893,"marketCap":4966484872},{"date":"2022-07-01","current":11.448483,"twenty":14.475592,"median":20.989133,"eighty":30.707893,"marketCap":4945744472},{"date":"2022-07-08","current":11.682046,"twenty":14.446312,"median":20.989133,"eighty":30.707893,"marketCap":5046643714},{"date":"2022-07-15","current":11.634035,"twenty":14.405366,"median":20.901381,"eighty":30.707893,"marketCap":5025903314},{"date":"2022-07-22","current":12.2945,"twenty":14.378471,"median":20.826627,"eighty":30.707893,"marketCap":5311223946},{"date":"2022-07-29","current":10.048078,"twenty":14.354753,"median":20.788925,"eighty":30.707893,"marketCap":5545534406},{"date":"2022-08-05","current":10.145269,"twenty":14.322523,"median":20.788925,"eighty":30.707893,"marketCap":5599173918},{"date":"2022-08-12","current":10.721601,"twenty":14.301896,"median":20.788925,"eighty":30.707893,"marketCap":5917251426},{"date":"2022-08-19","current":10.554902,"twenty":14.25908,"median":20.788925,"eighty":30.707893,"marketCap":5825250171},{"date":"2022-08-26","current":9.974504,"twenty":14.187553,"median":20.788925,"eighty":30.707893,"marketCap":5504928730},{"date":"2022-09-02","current":9.465258,"twenty":14.135304,"median":20.788925,"eighty":30.707893,"marketCap":5223876117},{"date":"2022-09-09","current":9.759015,"twenty":14.102002,"median":20.788925,"eighty":30.707893,"marketCap":5386000279},{"date":"2022-09-16","current":9.233506,"twenty":14.059394,"median":20.788925,"eighty":30.707893,"marketCap":5095971933},{"date":"2022-09-23","current":8.782199,"twenty":14.031264,"median":20.788925,"eighty":30.707893,"marketCap":4846895366},{"date":"2022-09-30","current":8.898075,"twenty":13.970918,"median":20.788925,"eighty":30.707893,"marketCap":4910847458},{"date":"2022-10-07","current":9.505917,"twenty":13.919195,"median":20.788925,"eighty":30.707893,"marketCap":5246315447},{"date":"2022-10-14","current":9.625859,"twenty":13.853034,"median":20.788925,"eighty":30.707893,"marketCap":5312511472},{"date":"2022-10-21","current":10.108676,"twenty":13.814554,"median":20.788925,"eighty":30.707893,"marketCap":5578978520},{"date":"2022-10-28","current":14.974971,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5630588980},{"date":"2022-11-04","current":15.463609,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5814316860},{"date":"2022-11-11","current":15.563653,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5851933626},{"date":"2022-11-18","current":15.647273,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5883374505},{"date":"2022-11-25","current":16.044465,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":6032718681},{"date":"2022-12-02","current":15.78614,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5935588822},{"date":"2022-12-09","current":14.866328,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5589739152},{"date":"2022-12-16","current":14.373571,"twenty":13.814554,"median":20.751188,"eighty":30.707893,"marketCap":5404462543},{"date":"2022-12-23","current":14.855875,"twenty":13.814554,"median":20.344302,"eighty":30.707893,"marketCap":5585809042},{"date":"2022-12-30","current":14.999223,"twenty":13.814554,"median":19.765377,"eighty":30.707893,"marketCap":5639707692},{"date":"2023-01-06","current":15.569626,"twenty":13.814554,"median":19.464991,"eighty":30.682769,"marketCap":5854179403},{"date":"2023-01-13","current":16.083288,"twenty":13.814554,"median":19.115452,"eighty":30.607602,"marketCap":6047316232},{"date":"2023-01-20","current":16.159441,"twenty":13.814554,"median":18.427296,"eighty":30.461812,"marketCap":6075949889},{"date":"2023-01-27","current":15.870494,"twenty":13.814554,"median":17.1977,"eighty":30.416074,"marketCap":6365655133},{"date":"2023-02-03","current":16.700552,"twenty":13.814554,"median":17.005108,"eighty":30.370928,"marketCap":6698591585},{"date":"2023-02-10","current":16.651561,"twenty":13.814554,"median":16.756543,"eighty":30.27693,"marketCap":6678941035},{"date":"2023-02-17","current":16.851727,"twenty":13.814554,"median":16.756543,"eighty":30.179893,"marketCap":6759227566},{"date":"2023-02-24","current":16.526982,"twenty":13.814554,"median":16.695284,"eighty":30.105575,"marketCap":6628972495},{"date":"2023-03-03","current":17.355997,"twenty":13.814554,"median":16.651561,"eighty":29.955493,"marketCap":6961490255},{"date":"2023-03-10","current":15.566371,"twenty":13.814554,"median":16.584753,"eighty":29.755722,"marketCap":6243671220},{"date":"2023-03-17","current":15.480547,"twenty":13.814554,"median":16.531531,"eighty":29.517526,"marketCap":6209247509},{"date":"2023-03-24","current":14.869936,"twenty":13.814554,"median":16.458394,"eighty":29.346477,"marketCap":5964331266},{"date":"2023-03-31","current":15.968755,"twenty":13.81764,"median":16.370108,"eighty":29.233228,"marketCap":6405067639},{"date":"2023-04-06","current":16.098193,"twenty":13.814554,"median":16.263207,"eighty":29.165128,"marketCap":6456985367},{"date":"2023-04-13","current":16.098193,"twenty":13.811468,"median":16.213847,"eighty":29.047766,"marketCap":6456985367},{"date":"2023-04-21","current":11.256514,"twenty":13.795287,"median":16.167243,"eighty":28.957812,"marketCap":4514987632},{"date":"2023-04-28","current":10.547063,"twenty":13.769342,"median":16.098193,"eighty":28.929603,"marketCap":4230427133},{"date":"2023-05-05","current":9.97455,"twenty":13.75401,"median":16.098193,"eighty":28.929603,"marketCap":4000792069},{"date":"2023-05-12","current":10.85153,"twenty":13.72131,"median":16.043818,"eighty":28.869244,"marketCap":4360144650},{"date":"2023-05-19","current":10.855892,"twenty":13.715462,"median":15.968755,"eighty":28.809081,"marketCap":4361897590},{"date":"2023-05-26","current":10.676792,"twenty":13.696628,"median":15.930768,"eighty":28.764729,"marketCap":4289934926},{"date":"2023-06-02","current":10.354878,"twenty":13.660339,"median":15.878021,"eighty":28.764729,"marketCap":4160590154},{"date":"2023-06-09","current":11.276849,"twenty":13.620925,"median":15.820484,"eighty":28.752181,"marketCap":4531038118},{"date":"2023-06-16","current":11.224609,"twenty":13.575222,"median":15.789127,"eighty":28.740612,"marketCap":4510047958},{"date":"2023-06-23","current":11.398273,"twenty":13.554976,"median":15.774827,"eighty":28.742195,"marketCap":4579826058},{"date":"2023-06-30","current":12.275063,"twenty":13.534076,"median":15.748467,"eighty":28.744691,"marketCap":4932120371},{"date":"2023-07-07","current":12.273651,"twenty":13.517745,"median":15.73232,"eighty":28.744691,"marketCap":4931553069},{"date":"2023-07-14","current":12.851119,"twenty":13.480736,"median":15.69546,"eighty":28.744691,"marketCap":5163579436},{"date":"2023-07-21","current":13.091142,"twenty":13.444539,"median":15.669077,"eighty":28.744691,"marketCap":5260020713},{"date":"2023-07-28","current":28.047249,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":5306539447},{"date":"2023-08-04","current":27.615476,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":5224848012},{"date":"2023-08-11","current":26.895854,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":5088695621},{"date":"2023-08-18","current":25.936359,"twenty":13.437725,"median":15.657467,"eighty":28.744691,"marketCap":4907159099},{"date":"2023-08-25","current":26.047301,"twenty":13.437725,"median":15.657467,"eighty":28.735863,"marketCap":4928149259},{"date":"2023-09-01","current":27.32163,"twenty":13.437725,"median":15.657467,"eighty":28.633914,"marketCap":5169252452},{"date":"2023-09-08","current":25.936359,"twenty":13.437725,"median":15.657467,"eighty":28.427306,"marketCap":4907159099},{"date":"2023-09-15","current":26.131256,"twenty":13.437725,"median":15.657467,"eighty":28.310023,"marketCap":4944033705},{"date":"2023-09-22","current":25.732466,"twenty":13.437725,"median":15.657467,"eighty":28.103852,"marketCap":4868582588},{"date":"2023-09-29","current":26.778916,"twenty":13.437725,"median":15.657467,"eighty":28.040876,"marketCap":5066570857},{"date":"2023-10-06","current":25.921367,"twenty":13.437725,"median":15.657467,"eighty":27.952179,"marketCap":4904322591},{"date":"2023-10-13","current":26.404113,"twenty":13.437725,"median":15.657467,"eighty":27.770815,"marketCap":4995658153},{"date":"2023-10-20","current":25.186753,"twenty":13.437725,"median":15.657467,"eighty":27.598634,"marketCap":4765333692},{"date":"2023-10-27","current":17.482305,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5309375955},{"date":"2023-11-03","current":18.634591,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5659325216},{"date":"2023-11-10","current":18.896496,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5738865978},{"date":"2023-11-17","current":19.770139,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6004191234},{"date":"2023-11-24","current":20.363168,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6184294245},{"date":"2023-12-01","current":19.770139,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6004191234},{"date":"2023-12-08","current":19.455852,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":5908742320},{"date":"2023-12-15","current":20.419291,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":6201338694},{"date":"2023-12-22","current":21.33222,"twenty":13.425722,"median":15.649693,"eighty":27.611266,"marketCap":6478595064},{"date":"2023-12-29","current":22.136644,"twenty":13.421721,"median":15.647273,"eighty":27.615476,"marketCap":6722898833},{"date":"2024-01-05","current":21.592254,"twenty":13.419632,"median":15.645413,"eighty":27.624048,"marketCap":6557567678},{"date":"2024-01-12","current":21.081538,"twenty":13.419632,"median":15.645413,"eighty":27.624048,"marketCap":6402463192},{"date":"2024-01-19","current":21.749398,"twenty":13.417543,"median":15.643553,"eighty":27.632621,"marketCap":6605292135},{"date":"2024-01-26","current":21.257389,"twenty":13.419632,"median":15.645413,"eighty":27.624048,"marketCap":6455869132},{"date":"2024-02-02","current":28.058844,"twenty":13.419632,"median":15.669077,"eighty":27.669555,"marketCap":7180258215},{"date":"2024-02-09","current":28.169854,"twenty":13.419632,"median":15.704121,"eighty":27.796495,"marketCap":7208665630},{"date":"2024-02-16","current":27.308418,"twenty":13.419632,"median":15.733099,"eighty":27.825797,"marketCap":6988224090},{"date":"2024-02-23","current":27.148564,"twenty":13.419632,"median":15.755466,"eighty":27.825797,"marketCap":6947317412},{"date":"2024-03-01","current":27.092062,"twenty":13.441726,"median":15.777181,"eighty":27.812943,"marketCap":6932858665},{"date":"2024-03-08","current":29.888075,"twenty":13.445242,"median":15.789127,"eighty":27.963376,"marketCap":7648358285},{"date":"2024-03-15","current":28.812755,"twenty":13.445242,"median":15.827779,"eighty":28.043716,"marketCap":7373184090},{"date":"2024-03-22","current":30.106708,"twenty":13.445242,"median":15.896443,"eighty":28.076477,"marketCap":7704306565},{"date":"2024-03-28","current":30.093322,"twenty":13.445242,"median":15.930965,"eighty":28.169854,"marketCap":7700881160},{"date":"2024-04-05","current":30.22941,"twenty":13.444539,"median":15.993577,"eighty":28.367293,"marketCap":7735706111},{"date":"2024-04-12","current":30.521665,"twenty":13.444539,"median":16.063876,"eighty":28.550678,"marketCap":7810494118},{"date":"2024-04-19","current":28.866298,"twenty":13.444539,"median":16.098193,"eighty":28.738359,"marketCap":7386885709},{"date":"2024-04-26","current":38.231767,"twenty":13.445242,"median":16.102434,"eighty":28.817217,"marketCap":8219830006},{"date":"2024-05-03","current":37.612546,"twenty":13.445242,"median":16.172772,"eighty":28.907655,"marketCap":8086697428},{"date":"2024-05-10","current":38.354269,"twenty":13.445242,"median":16.221256,"eighty":29.130483,"marketCap":8246167924},{"date":"2024-05-17","current":38.702534,"twenty":13.445242,"median":16.290002,"eighty":29.281518,"marketCap":8321044752},{"date":"2024-05-24","current":38.854069,"twenty":13.445242,"median":16.385606,"eighty":29.401797,"marketCap":8353624746},{"date":"2024-05-31","current":39.239552,"twenty":13.454387,"median":16.514415,"eighty":29.631749,"marketCap":8436503678},{"date":"2024-06-07","current":37.902323,"twenty":13.473236,"median":16.552178,"eighty":29.829217,"marketCap":8148999521},{"date":"2024-06-14","current":38.593535,"twenty":13.469601,"median":16.648062,"eighty":29.922236,"marketCap":8297610020},{"date":"2024-06-21","current":37.928908,"twenty":13.465967,"median":16.735546,"eighty":30.031355,"marketCap":8154715310},{"date":"2024-06-28","current":38.468585,"twenty":13.455063,"median":16.771844,"eighty":30.093322,"marketCap":8270745814},{"date":"2024-07-05","current":38.447317,"twenty":13.455063,"median":16.814111,"eighty":30.119103,"marketCap":8266173184},{"date":"2024-07-12","current":38.896605,"twenty":13.455063,"median":16.946902,"eighty":30.175867,"marketCap":8362770008},{"date":"2024-07-15","current":39.090676,"twenty":13.455063,"median":17.002596,"eighty":30.222173,"marketCap":8404495263},{"date":"2024-08-02","current":36.716509,"twenty":13.443132,"median":17.163621,"eighty":30.257604,"marketCap":8848678588},{"date":"2024-08-09","current":34.544426,"twenty":13.474636,"median":17.391968,"eighty":30.380644,"marketCap":8325206621},{"date":"2024-08-16","current":35.878536,"twenty":13.516412,"median":18.180924,"eighty":30.441623,"marketCap":8646727108},{"date":"2024-08-23","current":35.80732,"twenty":13.536427,"median":18.692584,"eighty":30.507515,"marketCap":8629564092},{"date":"2024-08-30","current":37.015615,"twenty":13.564424,"median":19.093862,"eighty":30.613864,"marketCap":8920763252},{"date":"2024-09-06","current":35.370529,"twenty":13.617967,"median":19.465206,"eighty":30.68362,"marketCap":8524297599},{"date":"2024-09-13","current":35.593672,"twenty":13.654447,"median":19.770139,"eighty":30.724008,"marketCap":8578075046},{"date":"2024-09-20","current":36.657162,"twenty":13.697093,"median":19.955344,"eighty":30.811628,"marketCap":8834376075},{"date":"2024-09-27","current":37.647062,"twenty":13.718449,"median":20.170481,"eighty":31.202877,"marketCap":9072941988},{"date":"2024-10-04","current":37.063092,"twenty":13.754547,"median":20.419291,"eighty":33.022546,"marketCap":8932205262},{"date":"2024-10-11","current":36.813837,"twenty":13.782708,"median":20.788925,"eighty":33.919642,"marketCap":8872134709},{"date":"2024-10-18","current":38.748534,"twenty":13.844231,"median":21.132049,"eighty":34.498848,"marketCap":9338396624},{"date":"2024-10-25","current":35.731356,"twenty":13.972834,"median":21.270485,"eighty":35.063709,"marketCap":8611256876},{"date":"2024-10-31","current":35.156674,"twenty":14.041756,"median":21.392084,"eighty":35.155808,"marketCap":9249721045},{"date":"2024-11-08","current":37.821894,"twenty":14.04673,"median":21.716135,"eighty":35.381924,"marketCap":9950940184},{"date":"2024-11-15","current":37.830595,"twenty":14.04673,"median":21.871932,"eighty":35.703819,"marketCap":9953229467},{"date":"2024-11-22","current":39.842745,"twenty":14.04673,"median":22.117001,"eighty":35.842453,"marketCap":10482626124},{"date":"2024-11-29","current":39.607813,"twenty":14.04673,"median":22.252579,"eighty":36.21515,"marketCap":10420815487},{"date":"2024-12-06","current":38.322212,"twenty":14.04673,"median":22.415358,"eighty":36.508084,"marketCap":10082573948},{"date":"2024-12-13","current":36.138213,"twenty":14.04673,"median":22.859046,"eighty":36.698326,"marketCap":9507963955},{"date":"2024-12-20","current":33.179809,"twenty":14.04673,"median":23.30284,"eighty":36.698326,"marketCap":8729607789},{"date":"2024-12-27","current":34.026,"twenty":14.04673,"median":23.434298,"eighty":36.698326,"marketCap":8952240545},{"date":"2025-01-03","current":32.842638,"twenty":14.04673,"median":23.518071,"eighty":36.698326,"marketCap":8640898079},{"date":"2025-01-10","current":33.425618,"twenty":14.045235,"median":23.729434,"eighty":36.704639,"marketCap":8794280029},{"date":"2025-01-17","current":33.814996,"twenty":14.045235,"median":23.80934,"eighty":36.704639,"marketCap":8896725436},{"date":"2025-01-24","current":35.437768,"twenty":14.045235,"median":23.953686,"eighty":36.704639,"marketCap":9323676686},{"date":"2025-01-31","current":33.333263,"twenty":14.045235,"median":23.956263,"eighty":36.531348,"marketCap":9823312666},{"date":"2025-02-07","current":33.556598,"twenty":14.045235,"median":23.956263,"eighty":36.222746,"marketCap":9889129548},{"date":"2025-02-14","current":32.746766,"twenty":14.045235,"median":23.956263,"eighty":35.878536,"marketCap":9650471812},{"date":"2025-02-21","current":33.306075,"twenty":14.045235,"median":23.956263,"eighty":35.814441,"marketCap":9815300176},{"date":"2025-02-28","current":31.197014,"twenty":14.045235,"median":23.956263,"eighty":35.764062,"marketCap":9193759885},{"date":"2025-03-07","current":29.524826,"twenty":14.045214,"median":23.954974,"eighty":35.772714,"marketCap":8700966306},{"date":"2025-03-14","current":29.365117,"twenty":14.045214,"median":23.967817,"eighty":35.772714,"marketCap":8653899927},{"date":"2025-03-21","current":29.877642,"twenty":14.045214,"median":24.116075,"eighty":35.772714,"marketCap":8804941148},{"date":"2025-03-28","current":30.412112,"twenty":14.045214,"median":24.170205,"eighty":35.772714,"marketCap":8962449399},{"date":"2025-04-04","current":28.45369,"twenty":14.045214,"median":24.30281,"eighty":35.772714,"marketCap":8385302378},{"date":"2025-04-11","current":27.414009,"twenty":14.045235,"median":24.43312,"eighty":35.764062,"marketCap":8078908592},{"date":"2025-04-17","current":27.614923,"twenty":14.045235,"median":24.592932,"eighty":35.764062,"marketCap":8138117897}],"updateTime":1745133320411}}}